These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6210423)

  • 41. [Fenoldopam: potential clinical applications in heart surgery].
    Shorten GD
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):487-91. PubMed ID: 11792308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine stimulates cAMP production in canine afferent arterioles via DA1 receptors.
    Tamaki T; Hura CE; Kunau RT
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H626-9. PubMed ID: 2538080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
    Goldberg LI
    Am J Med; 1984 Oct; 77(4A):37-44. PubMed ID: 6148892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The regulating effects of dopamine receptors on the level of adenosine 3, 5-cyclic monophosphate in bovine trabecular cells in vitro].
    Lu Y; Li M
    Zhonghua Yan Ke Za Zhi; 1998 Sep; 34(5):379-81. PubMed ID: 11877232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
    Lokhandwala MF; Sabouni MH
    J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Both DA1 and DA2 receptor agonists are necessary to inhibit NaKATPase activity in proximal tubules from rat kidney.
    Bertorello A; Aperia A
    Acta Physiol Scand; 1988 Mar; 132(3):441-3. PubMed ID: 2906504
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of long-term application of dopamine HCl on dopamine agonist-induced cAMP production in rat renal cortex.
    Zhao RR; Jin XH; Zhu L; Wang WZ
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):35-8. PubMed ID: 10375755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam.
    Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE
    J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral dopamine receptors.
    Kohli JD
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):25S-28S. PubMed ID: 2143385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension.
    Murphy MB; Murray C; Shorten GD
    N Engl J Med; 2001 Nov; 345(21):1548-57. PubMed ID: 11794223
    [No Abstract]   [Full Text] [Related]  

  • 51. Dopamine and the kidney in heart failure.
    Casagrande C
    Herz; 1991 Apr; 16(2):102-15. PubMed ID: 2066052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fenoldopam--but not dopamine--selectively increases gastric mucosal oxygenation in dogs.
    Schwarte LA; Picker O; Schindler AW; Fournell A; Scheeren TW
    Crit Care Med; 2003 Jul; 31(7):1999-2005. PubMed ID: 12847395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
    Lokhandwala MF; Watkins HO; Dlewati A
    Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
    Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
    J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1986 Jan; 21(1):53-61. PubMed ID: 2868748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of tetrahydroberberine on peripheral vascular dopamine DA1 and DA2 receptor subtypes].
    Zhang WF; Zhi JM; Guo W; Zhao RR; Jin GZ
    Zhongguo Zhong Yao Za Zhi; 2000 Aug; 25(8):497-500. PubMed ID: 12515216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulation of vascular dopamine receptors: status and future strategies.
    Berkowitz BA; Ohlstein EH
    Clin Exp Hypertens A; 1987; 9(5-6):1037-44. PubMed ID: 3304727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
    Brienza N; Malcangi V; Dalfino L; Trerotoli P; Guagliardi C; Bortone D; Faconda G; Ribezzi M; Ancona G; Bruno F; Fiore T
    Crit Care Med; 2006 Mar; 34(3):707-14. PubMed ID: 16505657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine: pharmacologic and therapeutic aspects.
    Velasco M; Luchsinger A
    Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.